|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 519/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K 5/062 | (2006.01) |
| (11) | Patento numeris | 3612537 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18718452.8 |
| Europos patento paraiškos padavimo data | 2018-04-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-02-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-13 |
| (46) | Apibrėžties vertimo paskelbimo data | 2022-10-10 |
| (86) | Numeris | PCT/EP2018/059846 |
| Data | 2018-04-18 |
| (87) | Numeris | WO 2018/192944 |
| Data | 2018-10-25 |
| (30) | Numeris | Data | Šalis |
| 201706133 | 2017-04-18 | GB | |
| 201721337 | 2017-12-19 | GB |
| (72) |
HOWARD, Philip Wilson , GB
GREGSON, Stephen John , GB
|
| (73) |
Medimmune Limited ,
Milstein Building
Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolobenzodiazepino konjugatai |
| PYRROLOBENZODIAZEPINE CONJUGATES |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2026-03-19 | 9 | 208.00 EUR |
| 2027-04-18 |